• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后早期的冠状动脉微血管疾病:诊断方法与预后价值——一篇叙述性综述

Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review.

作者信息

Sokratous Stefanos, Mitsis Andreas, Khattab Elina, Karelas Dimitrios, Velidakis Nikolaos, Kadoglou Nikolaos P E

机构信息

Medical School, University of Cyprus, 2029 Nicosia, Cyprus.

Department of Cardiology, General Hospital of Nicosia, 2031 Strovolos, Cyprus.

出版信息

Biomedicines. 2025 May 23;13(6):1289. doi: 10.3390/biomedicines13061289.

DOI:10.3390/biomedicines13061289
PMID:40564009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189317/
Abstract

Coronary microvascular disease (CMVD) is not an uncommon complication after acute myocardial infarction (AMI), independent of prompt revascularization. It is a serious yet underdiagnosed disease that has a major impact on patient outcomes. Even when the infarct-related artery is successfully revascularized, a significant percentage of patients still have compromised microvascular circulation, which is linked to higher cardiovascular mortality and hospitalization for heart failure. The well-known invasive methods, such as the index of microvascular resistance (IMR) and the coronary flow reserve (CFR), have been considered as gold standards. However, they are constrained by their hazards and complexity. Non-invasive techniques, such as echocardiography Doppler for CFR assessment, positron emission tomography (PET), cardiac magnetic resonance imaging (CMR), and some other techniques provide alternatives, but their accessibility, cost and implementation during the peri-AMI period raise obstacles to their wider use. This review highlights both invasive and non-invasive modalities as it examines the diagnostic methods and prognostic significance of CMVD development early after AMI. Enhancing long-term results in this high-risk population requires a thorough understanding of pathophysiology and a commitment to larger diagnostic and prognostic studies for CMVD.

摘要

冠状动脉微血管疾病(CMVD)是急性心肌梗死(AMI)后一种并不罕见的并发症,与及时的血运重建无关。它是一种严重但诊断不足的疾病,对患者的预后有重大影响。即使梗死相关动脉成功实现血运重建,仍有相当比例的患者微血管循环受损,这与更高的心血管死亡率和因心力衰竭住院有关。诸如微血管阻力指数(IMR)和冠状动脉血流储备(CFR)等知名的有创方法一直被视为金标准。然而,它们受到其风险和复杂性的限制。无创技术,如用于评估CFR的超声心动图多普勒、正电子发射断层扫描(PET)、心脏磁共振成像(CMR)以及其他一些技术提供了替代方法,但它们在AMI围术期的可及性、成本和实施过程对其更广泛应用构成了障碍。本综述在探讨AMI后早期CMVD发生的诊断方法和预后意义时,突出了有创和无创两种方式。要改善这一高危人群的长期预后,需要深入了解病理生理学,并致力于开展针对CMVD的更大规模的诊断和预后研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/343acad81cf0/biomedicines-13-01289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/11eb25101519/biomedicines-13-01289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/e6dceeb8ca2e/biomedicines-13-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/24cba3662843/biomedicines-13-01289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/343acad81cf0/biomedicines-13-01289-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/11eb25101519/biomedicines-13-01289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/e6dceeb8ca2e/biomedicines-13-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/24cba3662843/biomedicines-13-01289-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4976/12189317/343acad81cf0/biomedicines-13-01289-g004.jpg

相似文献

1
Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review.心肌梗死后早期的冠状动脉微血管疾病:诊断方法与预后价值——一篇叙述性综述
Biomedicines. 2025 May 23;13(6):1289. doi: 10.3390/biomedicines13061289.
2
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
3
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
4
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
7
Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.急性心肌梗死直接血管成形术的临床疗效与成本效益:系统评价与经济学评估
Health Technol Assess. 2005 May;9(17):1-99, iii-iv. doi: 10.3310/hta9170.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
The Index of Microcirculatory Resistance After Primary PCI: A Pooled Analysis of Individual Patient Data.直接经皮冠状动脉介入治疗后微血管阻力指数:一项个体患者数据分析的汇总分析。
JACC Cardiovasc Interv. 2023 Oct 9;16(19):2383-2392. doi: 10.1016/j.jcin.2023.08.030.

本文引用的文献

1
Coronary microvascular dysfunction: pathophysiology, diagnosis, and therapeutic strategies across cardiovascular diseases.冠状动脉微血管功能障碍:心血管疾病中的病理生理学、诊断及治疗策略
EXCLI J. 2025 Mar 26;24:454-478. doi: 10.17179/excli2025-8285. eCollection 2025.
2
Mechanism of Coronary Microcirculation Obstruction after Acute Myocardial Infarction and Cardioprotective Strategies.急性心肌梗死后冠状动脉微循环障碍的机制及心脏保护策略
Rev Cardiovasc Med. 2024 Oct 12;25(10):367. doi: 10.31083/j.rcm2510367. eCollection 2024 Oct.
3
Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Non-ST-Segment Elevation Myocardial Infarction Patients.
非 ST 段抬高型心肌梗死患者冠状动脉造影衍生的微血管阻力指数的预后价值。
JACC Cardiovasc Interv. 2024 Aug 26;17(16):1874-1886. doi: 10.1016/j.jcin.2024.04.048. Epub 2024 Aug 7.
4
Prognostic Implications of Resistive Reserve Ratio in Patients With Nonobstructive Coronary Artery Disease With Myocardial Bridging.心肌桥伴非阻塞性冠状动脉疾病患者阻力储备比的预后意义。
J Am Heart Assoc. 2024 Aug 6;13(15):e035000. doi: 10.1161/JAHA.124.035000. Epub 2024 Jul 31.
5
Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications.非阻塞性冠状动脉心肌缺血的有创功能性冠状动脉评估:从病理生理机制到临床意义
Rev Cardiovasc Med. 2022 Oct 31;23(11):371. doi: 10.31083/j.rcm2311371. eCollection 2022 Nov.
6
The Impact of Microvascular Resistance Reserve on the Outcome of Patients With STEMI.微血管阻力储备对 STEMI 患者预后的影响。
JACC Cardiovasc Interv. 2024 May 27;17(10):1214-1227. doi: 10.1016/j.jcin.2024.03.024. Epub 2024 May 14.
7
Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction.经皮冠状动脉介入治疗后心肌梗死患者微血管阻力储备的预后价值
J Am Coll Cardiol. 2024 May 3. doi: 10.1016/j.jacc.2024.02.052.
8
Left ventricular diastolic function and cardiotoxic chemotherapy.左心室舒张功能与心脏毒性化疗
Egypt Heart J. 2024 Apr 12;76(1):45. doi: 10.1186/s43044-024-00476-4.
9
A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension.肺动脉高压中心肺微血管功能障碍综述
Am Heart J Plus. 2023 Jan 20;26:100255. doi: 10.1016/j.ahjo.2023.100255. eCollection 2023 Feb.
10
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction.急性心肌梗死患者的冠状动脉微血管阻塞和功能障碍。
Nat Rev Cardiol. 2024 May;21(5):283-298. doi: 10.1038/s41569-023-00953-4. Epub 2023 Nov 24.